A Active-controlled, Study of Paliperidone Palmitate 6-Month Formulation
This study is completed in the United States, in Australia, in France, .... It is testing PP6M for Schizophrenia.
SchizophreniaDrugFrom 18 Years to 70 Years
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Then choose your country and confirm availability with each study site.
In plain English
Key information made simple
What is this study testing?
This study is testing whether Paliperidone Palmitate 6-Month Formulation may be useful for adults experiencing schizophrenia.
What would participation involve?
Participants may receive Paliperidone Palmitate 6-Month Formulation, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in Argentina, in Australia, and in Brazil.
Who is it mainly for?
This study appears to be mainly for adults with schizophrenia.
What should you check before joining?
Ask about the dose, safety monitoring, and possible side effects, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.
Your next step
Check the study details
Check the official source, then confirm these points with the research team.
California Pharmaceutical Research Institute, Inc.
Anaheim, California
Site status: Not listed — confirm with the team
ATP Clinical Research
Costa Mesa, California
Site status: Not listed — confirm with the team
Collaborative NeuroScience Network
Garden Grove, California
Site status: Not listed — confirm with the team
Synergy East
Lemon Grove, California
Site status: Not listed — confirm with the team
Pacific Research Partners
Oakland, California
Site status: Not listed — confirm with the team
SF-Care, Inc
San Rafael, California
Site status: Not listed — confirm with the team
New Life Medical Research Center, Inc.
Hialeah, Florida
Site status: Not listed — confirm with the team
Clintex Research Group
Miami, Florida
Site status: Not listed — confirm with the team
Florida Research Center Inc.
Miami, Florida
Site status: Not listed — confirm with the team
Olympian Clinical Research
Tampa, Florida
Site status: Not listed — confirm with the team
Atlanta Center for Medical Research
Atlanta, Georgia
Site status: Not listed — confirm with the team
Uptown Research Institute
Chicago, Illinois
Site status: Not listed — confirm with the team
Alexian Behavioral Health Hospital
Hoffman Estates, Illinois
Site status: Not listed — confirm with the team
Ascension via Christi Research
Wichita, Kansas
Site status: Not listed — confirm with the team
Massachusetts General Hospital
Boston, Massachusetts
Site status: Not listed — confirm with the team
Cherry Street Services, Inc.
Grand Rapids, Michigan
Site status: Not listed — confirm with the team
St. Louis Clinical Trials
St Louis, Missouri
Site status: Not listed — confirm with the team
The Zucker Hillside Hospital
Glen Oaks, New York
Site status: Not listed — confirm with the team
Clinical Trials of America Inc
Hickory, North Carolina
Site status: Not listed — confirm with the team
Wexner Medical Center at the Ohio State University
Columbus, Ohio
Site status: Not listed — confirm with the team
Midwest Clinical Research Center
Dayton, Ohio
Site status: Not listed — confirm with the team
University of Pennsylvania Medical Center
Philadelphia, Pennsylvania
Site status: Not listed — confirm with the team
Future Search Trials of Dallas
Dallas, Texas
Site status: Not listed — confirm with the team
Psychiatric and Behavioral Solutions
Salt Lake City, Utah
Site status: Not listed — confirm with the team
Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT03345342. We help you review the study, but cannot decide medical eligibility.
In practice
For you
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Study sites are listed. Confirm the relevant site and any travel before making plans.
Important
Not medical advice
Information from public sources.
Are you the study sponsor? Contact us to update this page: hi@hopestage.com
FAQ
Questions about this study
What is this study trying to understand?
This study is exploring medication or study treatment for people with schizophrenia. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
Does this study involve a medication?
This appears to be a medication / drug study involving PP6M, PP3M 350 mg eq., PP3M 525 mg eq., PP1M, Placebo. Phase 3 studies are usually larger and aim to confirm effectiveness and safety in a broader group.
Who might this study be for?
This study may concern people with schizophrenia; age range: From 18 Years to 70 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
What side effects, interactions, or treatment changes should I check?
If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by Janssen Research & Development, LLC, which appears to be another type of organization. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Explore other studies
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
